Process for manufacture of telmisartan

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S300100, C548S301700, C548S302700

Reexamination Certificate

active

10802142

ABSTRACT:
A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1′-methylbenzimidazol-2′-yl)benzimidazole with a compound of formula (IV)wherein Z is a leaving group, to obtain the compound 2-cyano-4′-[2″-n-propyl-4″-methyl-6″-(1′″-methylbenzimidazol-2′″-yl)benzimidazol-1″-ylmethyl]biphenyl, and subsequently hydrolyzing the nitrile function to obtain the acid function.

REFERENCES:
patent: 5591762 (1997-01-01), Hauel et al.
patent: 6358986 (2002-03-01), Schneider
patent: 6410742 (2002-06-01), Schneider
patent: 6737432 (2004-05-01), Donsbach
patent: WO 00/43370 (2000-07-01), None
Cottineau, Bertrand, et al; Synthesis and Hypoglycemic Evaluation of Substituted Pyrazole-4-carboxylic Acids; Bioorganic and Medicinal Chemistry Letters, XP-002280950.
Mederski, Werner, W.K.R. et al; Non-Peptide Angiotensis II Receptor Antagonists: Synthesis and Biologicial Activity of a Series of Novel 4,5-Dihydro-4-oxo-3H imidazo[4,5-c]pyridine Derivatives. J. Med. Chem. 1994,037,01632-1645 XP 002129108.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process for manufacture of telmisartan does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for manufacture of telmisartan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for manufacture of telmisartan will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3759098

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.